November 24, 2014

March of Dimes and University of Pennsylvania Announce Launch of Prematurity Research Center

Informative and inspirational ribbon-cutting ceremony furthers resolve of corporate partners.

SAN ANTONIO, TX (November 24, 2014) — This week on World Prematurity Day, the March of Dimes Foundation and the Perelman School of Medicine at the University of Pennsylvania celebrated the establishment of the March of Dimes Prematurity Research Center at the university. Over the next five years, the March of Dimes has committed to invest $10 million to create the new transdisciplinary center designed to accelerate research aimed at discovering the causes of preterm birth and new strategies to prevent it.

The announcement and ribbon-cutting ceremony were held at the University of Pennsylvania Hospital in Philadelphia on November 17, and a celebratory luncheon followed at the university’s Biomedical Research Building. Presenters during the day included Dr. Jennifer L. Howse, President, March of Dimes Foundation; Dr. Deborah A. Driscoll, Department of Obstetrics Chair and Principal Investigator; Anne Geddes, acclaimed baby photographer and March of Dimes Volunteer Ambassador; and Darwin Walker, retired defensive tackle for the Philadelphia Eagles.

The project is part of a “medical Manhattan Project” of five such centers in the United States created by the foundation. The first opened in 2011 at Stanford University School of Medicine. The Ohio Collaborative, a partnership of leading research centers in Cincinnati, Columbus and Cleveland, launched in 2013. And the Prematurity Research Center at Washington University in St. Louis was launched on November 10. Announcement of the fifth center has not yet been made.

Among those in attendance at the announcement was Peter Marchesini, Chief Operating Officer, Alamo Pharma Services, a subsidiary of Mission Pharmacal Company. “Mission shares the March of Dimes’ passion for healthy babies and our support of its initiatives is an extension of our company’s corporate beliefs,” notes Marchesini. “Being at the celebration and learning how this collaborative effort will help uncover the causes of preterm deliveries and ultimately find solutions to those causes was inspiring. These types of initiatives certainly strengthen our commitment to all involved.”

Mission Pharmacal Company has been a national sponsor of March for Babies®, the March of Dimes® premier fundraising event, since 2009.

About the March of Dimes

The March of Dimes works to improve the health of babies by preventing birth defects, premature birth, and infant mortality. The March of Dimes is the leading nonprofit organization for pregnancy and baby health. For more than 75 years, moms and babies have benefited from March of Dimes research, education, vaccines, and breakthroughs.

About Mission Pharmacal Company

Mission Pharmacal Company is a privately held pharmaceutical company based in San Antonio, Texas. For more than 65 years, the company has been committed to meeting the unique healthcare needs of women throughout all stages of life, pediatric patients, and those persons dealing with urologic and dermatologic conditions. The company has a proven track record of identifying unmet healthcare needs and developing both innovative prescription and over-the-counter products to meet these needs. Using only the purest ingredients and FDA-approved methods of manufacturing, Mission Pharmacal provides physicians and consumers with the highest quality pharmaceutical and dietary supplement products on the market today. Mission Pharmacal is a proud national supporter of the March of Dimes Foundation®, whose mission is to improve the health of babies by preventing birth defects, premature birth, and infant mortality. For more information about the company, visit

Are you a media professional? We’re happy to help you build your story with information about Alamo Pharma Services or interviews with company representatives.